San Diego, CA · Founded 2020 · Privately Held (backing)
Developer of covalent protein therapeutics intended to deliver efficacious and safer treatments. Enlaza Therapeutics is based in San Diego, CA and was founded in 2020. It was valued at $295 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $176 million across 3 recorded rounds; the latest was a $15 million early-stage round in Aug 2025.
PMV mark · valuation
$295.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$176.0M
Last round
Early Stage VC
Aug 2025
Team — not yet on record
No current team members for Enlaza Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enlaza Therapeutics with a free account
·The complete investor list: 13 names
·Watch Enlaza Therapeutics: the Monday email on marks, rounds and moves
